Bausch Health Companies (BHC) Change in Inventory (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Change in Inventory came in at $22.0 million in Q2 2026, up 414.29% year-over-year from $4.3 million in Q2 2025, and up 57.14% quarter-over-quarter from $14.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Change in Inventory (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Change in Inventory across 18 years of filings, most recently posting $22.0 million for Q2 2026.
- In Q2 2026, Change in Inventory rose 414.29% year-over-year to $22.0 million; the TTM figure through Jun 2026 stood at $25.0 million (down 78.07% YoY), while the FY2025 annual figure was $12.0 million, down 95.51% from the prior year.
- Change in Inventory came in at $22.0 million for Q2 2026 at Bausch Health Companies, up from $14.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $144.0 million in Q1 2024 to a low of -$16.0 million in Q3 2025.
- Average Change in Inventory over 5 years is $46.4 million, with a median of $37.0 million recorded in 2023.
- Year-over-year, Change in Inventory surged 2400.0% in 2023 and tumbled 138.1% in 2025.
- Over 5 years, Change in Inventory stood at $4.0 million in 2022, then surged by 2400.0% to $100.0 million in 2023, then slumped by 51.0% to $49.0 million in 2024, then tumbled by 89.8% to $5.0 million in 2025, then jumped by 340.0% to $22.0 million in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $22.0 million in Q2 2026, $14.0 million in Q1 2026, and $5.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -59.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 99.50 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -76.69 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 69.19 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 22.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -403,000.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -305,000.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 9.88 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Sep 30, 2024 | 42.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Mar 31, 2024 | 144.00 Mn |
| Dec 31, 2023 | 100.00 Mn |
| Sep 30, 2023 | 62.00 Mn |
| Jun 30, 2023 | 32.00 Mn |
| Mar 31, 2023 | 128.00 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 56.00 Mn |
| Jun 30, 2022 | 65.00 Mn |
| Mar 31, 2022 | 73.00 Mn |
| Dec 31, 2021 | -46.00 Mn |
| Sep 30, 2021 | 15.00 Mn |